In 2014, the Italian Medicines Agency (AIFA) amended the summary of product characteristics of codeine-containing medications limiting their use for maximum three days. This study attempted to clarify the impact of AIFA intervention on prescribing trends and appropriateness of use of codeine-containing medications and other opioids.
Prescribing Trends of Codeine-containing Medications and Other Opioids in Primary Care After A Regulatory Decision: An Interrupted Time Series Analysis / Lombardi, Niccolò; Vannacci, Alfredo; Bettiol, Alessandra; Marconi, Ettore; Pecchioli, Serena; Magni, Alberto; Cricelli, Claudio; Lapi, Francesco. - In: CLINICAL DRUG INVESTIGATION. - ISSN 1173-2563. - ELETTRONICO. - 39:(2019), pp. 455-462. [10.1007/s40261-019-00767-8]
Prescribing Trends of Codeine-containing Medications and Other Opioids in Primary Care After A Regulatory Decision: An Interrupted Time Series Analysis
Lombardi, Niccolò;Vannacci, Alfredo;Bettiol, Alessandra;Marconi, Ettore;Lapi, Francesco
2019
Abstract
In 2014, the Italian Medicines Agency (AIFA) amended the summary of product characteristics of codeine-containing medications limiting their use for maximum three days. This study attempted to clarify the impact of AIFA intervention on prescribing trends and appropriateness of use of codeine-containing medications and other opioids.
| File | Dimensione | Formato | |
|---|---|---|---|
|
31 Lombardi N et al, 2019.pdf
accesso aperto
Tipologia:
Versione finale referata (Postprint, Accepted manuscript)
Licenza:
Open Access
Dimensione
1.07 MB
Formato
Adobe PDF
|
1.07 MB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
